...
首页> 外文期刊>Therapeutics and Clinical Risk Management >Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis
【24h】

Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis

机译:每日两次氮卓斯汀鼻喷剂对季节性变应性鼻炎的疗效

获取原文
           

摘要

Azelastine nasal spray (Allergodil?, Lastin?, Afluon?; Meda AB, Stockholm, Sweden) is a fast-acting, efficacious and well-tolerated H1-receptor antagonist for the treatment of rhinitis. In addition it also has mast-cell stabilizing and anti-inflammatory properties, reducing the concentration of leukotrienes, kinins and platelet activating factor in vitro and in vivo, as well as inflammatory cell migration in rhinitis patients. Well-controlled studies in patients with seasonal allergic rhinitis (SAR), perennial rhinitis (PR) or vasomotor rhinitis (VMR) confirm that azelastine nasal spray has a rapid onset of action, and improves nasal symptoms associated with rhinitis such as nasal congestion and post-nasal drip. Azelastine nasal spray is effective at the lower dose of 1 spray as well at a dose of 2 sprays per nostril twice daily, but with an improved tolerability profi le compared to the 2-spray per nostril twice daily regimen. Compared with intranasal corticosteroids, azelastine nasal spray has a faster onset of action and a better safety profile, showing at least comparable efficacy with fluticasone propionate (Flonase?; GSK,USA), and a superior efficacy to mometasone furoate (Nasonex?; Schering Plough, USA). In combination with fluticasone propionate, azelastine nasal spray exhibits greater efficacy than either agent used alone, and this combination may provide benefit for patients with difficult to treat seasonal allergic rhinitis. In addition, azelastine nasal spray can be used on an as-needed basis without compromising clinical efficacy. Compared with oral antihistamines, azelastine nasal spray also demonstrates superior efficacy and a more rapid onset of action, and is effective even in patients who did not respond to previous oral antihistamine therapy. Unlike most oral antihistamines, azelastine nasal spray is effective in alleviating nasal congestion, a particularly bothersome symptom for rhinitis suffers. Azelastine nasal spray is well tolerated in both adults and children with allergic rhinitis. Bitter taste which seems to be associated with incorrect dosing technique is the most common side effect reported by patients, but this problem can be minimized by correct dosing technique.
机译:氮卓斯汀鼻喷雾剂(Allergodil ?,Lastin ?,Afluon ?;瑞典斯德哥尔摩Meda AB)是一种速效,有效且效果良好的喷雾剂耐受的H1受体拮抗剂治疗鼻炎。此外,它还具有肥大细胞稳定和抗炎特性,在体外和体内降低白三烯,激肽和血小板活化因子的浓度,以及在鼻炎患者中引起炎性细胞迁移。对季节性过敏性鼻炎(SAR),常年性鼻炎(PR)或血管舒缩性鼻炎(VMR)的患者进行的对照研究证实,氮卓斯汀鼻喷剂起效迅速,并改善了与鼻炎有关的鼻部症状,例如鼻塞和鼻后-滴鼻液。氮卓斯汀鼻喷雾剂在较低剂量的1剂喷雾剂以及每天两次每次鼻孔的2剂喷雾剂中有效,但是与每天两次鼻息剂的2次喷雾剂相比,耐受性有所改善。与鼻内皮质类固醇相比,氮卓斯汀鼻喷雾剂起效更快,安全性更好,显示出至少与丙酸氟替卡松相当的功效(Flonase ?; GSK,美国),并且优于莫米松糠酸酯(Nasonex ?;美国先灵P雅)。与丙酸氟替卡松联用,氮卓斯汀鼻喷雾剂比单独使用任何一种药物都具有更高的功效,这种组合可能为难以治疗季节性变应性鼻炎的患者带来益处。此外,氮卓斯汀鼻喷雾剂可以根据需要使用,而不会影响临床疗效。与口服抗组胺药相比,氮卓斯汀鼻喷雾剂还显示出优异的疗效和更迅速的起效,甚至对先前口服抗组胺药没有反应的患者也有效。与大多数口服抗组胺药不同,氮卓斯汀鼻喷雾剂可有效缓解鼻塞,鼻塞是一种特别令人讨厌的症状。成人和儿童过敏性鼻炎对氮卓斯汀的鼻腔喷雾剂耐受良好。似乎与不正确的剂量技术有关的苦味是患者报告的最常见的副作用,但是可以通过正确的剂量技术将这一问题最小化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号